• FAQ's

    FAQ Library

    Respected thought leaders answer frequently asked questions on issues important to your practice – available in video, audio, and transcript formats.

  • FAQ's

    Meeting Highlights

    Video and written highlights from major annual meetings regarding the most current multiple myeloma clinical study findings–one of our most popular features!

  • FAQ's

    Expert Interviews

    A comprehensive array of indepth, evidence-based discussions with prominent thought leaders related to myeloma patient care–available in video, audio, and transcript formats.

  • FAQ's

    CE Activities

    Accredited activities that focus on the assessment, diagnosis and treatment of multiple myeloma. Each activity highlights clinically relevant, timely and accurate scientific information, designed to support you in your search for additional education and improved patient care.

  • FAQ's
  • NIH Center of Excellence in Pain Education
  • ASH 2012 Highlights
  • Treatment & Maintenance Therapy for Prolonging Remission & Delaying Response in Follicular Lymphoma
  • New Paradigms in Chronic Myelogenous Leukemia

What's New

Expert Commentary
Subcutaneous Administration of Bortezomib
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Patient Care Tool
Quick Reference: Symptom Management Throughout Stem Cell Transplant
CE Activity
Novel Approaches for the Management of Elderly and Infirm Multiple Myeloma Patients
Antonio Palumbo, MD, and Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
CE Activity
Advances in Consolidation, Stem Cell Collection, and Transplantation
Sergio A. Giralt, MD, and Beth Faiman, RN, MSN, APRN-BC, AOCN®
FAQ Library
How can you ensure patients are reporting side effects?
Robert Z. Orlowski, MD, PhD
FAQ Library
What is the CyBorD regimen's safety and efficacy as a primary therapy?
Robert Z. Orlowski, MD, PhD
Clinical Trials
New Clinical Trials for Relapsed/refractory
Journal Club Library
Four abstracts posted for April